Related Experiment Videos

Effects of hydrocortisone and cholecystokinin-octapeptide on neonatal rat pancreas

Insights

Newborn rats treated with hydrocortisone and cholecystokinin-octapeptide (CCK-8) showed increased pancreatic growth and enzyme activity. However, hydrocortisone later reduced pancreatic amylase secretion, while CCK-8 enhanced it.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Gastroenterology

Background:

  • The development and function of the pancreas are crucial for digestion.
  • Hormonal regulation plays a significant role in organ development during early life.

Purpose of the Study:

  • To investigate the effects of hydrocortisone and cholecystokinin-octapeptide (CCK-8) on the growth and secretory capacity of the newborn rat pancreas.
  • To understand the distinct roles of glucocorticoids and CCK-8 in pancreatic development.

Main Methods:

  • Newborn rats were injected with hydrocortisone or CCK-8 from days 1-5 of life.
  • Pancreatic weight, protein, and DNA content were measured.
  • Specific activities of digestive enzymes (amylase, chymotrypsinogen, lipase) were assessed.
  • Pancreatic amylase secretion in response to carbachol and basal secretion were measured at 7 days of age.

Main Results:

  • Both hydrocortisone and CCK-8 significantly increased pancreatic weight, protein, and DNA content.
  • Specific activities of amylase, chymotrypsinogen, and lipase were elevated by both agents.
  • Hydrocortisone administration at 7 days decreased the pancreas's ability to secrete amylase in response to carbachol.
  • CCK-8 administration at 7 days increased basal pancreatic secretion.

Conclusions:

  • Glucocorticoids and cholecystokinin are key regulators of newborn rat pancreatic growth.
  • These hormones differentially influence the secretory capacity of the developing pancreas.
  • Early-life hormonal exposure has lasting effects on pancreatic function.

Related Concept Videos